Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report

BACKGROUND: Interferon alpha2 is widely used in hepatitis and high-risk melanoma. Interferon-induced pulmonary arterial hypertension as a side effect is rare. CASE PRESENTATION: We describe a melanoma patient who developed severe pulmonary arterial hypertension 30 months after initiation of adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Jochmann, Nicoline, Kiecker, Felix, Borges, Adrian C, Hofmann, Maja A, Eddicks, Stephan, Sterry, Wolfram, Baumann, Gert, Trefzer, Uwe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208925/
https://www.ncbi.nlm.nih.gov/pubmed/16138923
http://dx.doi.org/10.1186/1476-7120-3-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208925/
https://www.ncbi.nlm.nih.gov/pubmed/16138923
http://dx.doi.org/10.1186/1476-7120-3-26

Ejemplares similares